Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of TBE-vaccine to Patients With Rheumatic Disease Who Are Treated With Methotrexate and/or TNF-alfa Blocking Drugs

NCT01131910 is registered in ClinicalTrials.gov with Sormland County Council, Sweden as lead sponsor.

NCT NCT01131910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01131910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of TBE-vaccine to Patients With Rheumatic Disease Who Are Treated With Methotrexate and/or TNF-alfa Blocking Drugs
Lead sponsor
Sormland County Council, Sweden
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2010
Completion date
May 31, 2011
Enrollment
68 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

exposed to tbe-virus, immunosuppression, rheumatoid arthritis